Clinical Study
Expression and Significances of Contactin-1 in Human Gastric Cancer
Table 3
Correlation of clinicopathologic parameters with VEGF-C, VEGFR-3, and CNTN-1 expression in gastric cancer (
/%).
| Clinicopathological features | Total cases | VEGF-C | VEGFR-3 | CNTN-1 | (+) | (−) | P | (+) | (−) | P | (+) | (−) | P |
| Age (ys) | | | | 0.925 | | | | | | 0.972 | ≧60 | 69/65.7 | 39/66.1 | 30/65.2 | | 47/69.1 | 22/59.5 | | 40/65.6 | 29/65.9 | | <60 | 36/34.3 | 20/33.9 | 16/34.8 | | 21/30.9 | 16/40.5 | | 21/34.4 | 15/34.1 | | Gender | | | | 0.676 | | | 0.571 | | | 0.545 | Male | 73/69.5 | 42/71.2 | 31/67.4 | | 46/67.6 | 27/73.0 | | 41/67.2 | 32/72.7 | | Female | 32/30.5 | 17/28.8 | 15/32.6 | | 22/32.4 | 10/27.0 | | 20/34.8 | 12/27.3 | | Tumor size | | | | 0.177 | | | 0.317 | | | 0.035 | ≧5 cm | 58/55.2 | 36/61.0 | 22/47.8 | | 40/58.8 | 18/48.6 | | 39/63.9 | 19/43.2 | | <5 cm | 47/44.8 | 23/39.0 | 24/52.2 | | 28/41.2 | 19/51.4 | | 22/36.1 | 25/56.8 | | Tumor location | | | | 0.218 | | | 0.320 | | | 0.098 | Upper | 17/16.2 | 11/18.6 | 6/13.0 | | 13/19.1 | 4/10.8 | | 6/9.8 | 11/25.0 | | Middle | 34/32.4 | 15/25.5 | 19/41.3 | | 19/27.9 | 15/40.5 | | 20/32.8 | 14/31.8 | | Lower | 54/51.4 | 33/55.9 | 21/45.7 | | 36/52.9 | 18/58.7 | | 35/57.4 | 19/43.2 | | Lauren’s classification | | | | 0.071 | | | 0.885 | | | 0.328 | Intestinal | 70/66.7 | 35/59.3 | 35/76.1 | | 45/66.2 | 25/67.6 | | 43/70.5 | 27/61.4 | | Diffuse | 35/33.3 | 24/40.7 | 11/23.9 | | 23/33.8 | 12/32.4 | | 18/29.5 | 17/38.6 | | TNM stage | | | | 0.001 | | | <0.001 | | | 0.002 | I + II | 41/39.0 | 15/25.4 | 26/56.5 | | 18/26.5 | 23/62.2 | | 16/26.2 | 25/56.8 | | III + IV | 64/61.0 | 44/74.6 | 20/43.5 | | 50/73.5 | 14/37.8 | | 45/73.8 | 19/43.2 | | Vascular invasion | | | | 0.526 | | | 0.179 | | | 0.385 | (+) | 26/24.8 | 16/32.2 | 10/15.2 | | 14/20.6 | 12/32.4 | | 17/27.9 | 9/20.5 | | (−) | 79/75.2 | 43/67.8 | 36/84.8 | | 54/79.4 | 25/67.6 | | 44/72.1 | 35/79.5 | | Serosa invasion | | | | 0.363 | | | 0.084 | | | 0.148 | (+) | 37/35.2 | 23/39.0 | 14/30.4 | | 28/41.2 | 9/24.3 | | 18/29.5 | 19/43.2 | | (−) | 68/64.8 | 36/61.0 | 32/69.6 | | 40/58.8 | 28/75.7 | | 43/70.5 | 25/56.8 | | Lymphatic invasion | | | | <0.001 | | | <0.001 | | | 0.001 | (+) | 66/62.9 | 49/83.1 | 17/37.0 | | 54/79.4 | 12/32.4 | | 47/77.0 | 19/43.2 | | (−) | 39/37.1 | 10/16.9 | 29/63.0 | | 14/20.6 | 25/67.6 | | 14/23.0 | 25/56.8 | | Lymph node metastasis | | | | <0.001 | | | <0.001 | | | <0.001 | (+) | 70/66.7 | 49/83.1 | 21/45.7 | | 54/79.4 | 16/43.2 | | 50/82.0 | 20/45.5 | | (−) | 35/33.3 | 10/16.9 | 25/54.3 | | 14/20.6 | 21/56.8 | | 11/18.0 | 24/54.5 | |
|
|